Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (16)
  • 2025 (97)
  • 2024 (68)
  • 2023 (66)
  • 2022 (91)
  • 2021 (120)
  • 2020 (88)
  • 2019 (86)
  • 2018 (86)
  • 2017 (67)
  • 2016 (69)
  • 2015 (69)
  • 2014 (79)
  • 2013 (90)
  • 2012 (14)
  • 2011 (78)
  • 2005 (2)

Subject

  • Drug Trafficking (294)
  • OCDETF/Task Force (65)
  • Prescription Drugs (42)
  • Take Back Day (37)
  • Guns/Weapons (33)
  • Synthetic drugs (33)
  • Guilty Plea (29)
  • Fake Pills (25)
  • Outreach/Drug Prevention (25)
  • Overdose (25)
  • Diversion Division (23)
  • Pharmaceuticals/Pharmacists/Physicians (21)
  • Seizures (Drugs/Property) (20)
  • Public and Media Affairs - also see Congressional Affairs (17)
  • Fentanyl Awareness (16)
  • Money Laundering (16)
  • Major Law Enforcement Operation (13)
  • Arrests/Convictions - Major (12)
  • Congressional Affairs (12)
  • One Pill Can Kill (12)
  • Press Conferences (11)
  • Red Ribbon (9)
  • Prevention/Education - DEA websites GSAD, JTT etc (8)
  • Gangs (6)
  • Extraditions (5)
  • Critical Incident (4)
  • Dark Web- Internet Trafficking (4)
  • Intergovernmental Affairs (4)
  • International/Foreign Operations (4)
  • Narcoterrorism (4)
  • Counterfeit Pills (3)
  • Fentanyl Free America (3)
  • Campaigns (2)
  • HIDTA (2)
  • Scam Calls (2)
  • Task Forces/Task Force Officers (2)
  • Terrorism (2)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Other (1)

Drug Name

  • Methamphetamine (246)
  • Fentanyl (153)
  • Cocaine (141)
  • Heroin (82)
  • Marijuana (Cannabis) (56)
  • Oxycodone (55)
  • Synthetic Opioids (20)
  • Opioids (12)
  • Hydromorphone (7)
  • Ecstasy/MDMA (6)
  • Marijuana Concentrates (3)
  • Benzodiazepines (2)
  • LSD (2)
  • Psilocybin (2)
  • Barbiturates (1)
  • GHB (1)
  • Ketamine (1)
  • Methadone (1)
  • Morphine (1)
  • Peyote & Mescaline (1)
  • Steroids (1)

Field Division

  • New England (2385)
  • New York (1521)
  • Houston (907)
  • San Francisco (847)
  • Miami (840)
  • Seattle (813)
  • St. Louis (808)
  • Chicago (629)
  • Washington, DC (617)
  • New Jersey (493)
  • New Orleans (481)
  • Detroit (361)
  • El Paso (350)
  • Dallas (315)
  • Los Angeles (300)
  • Phoenix (274)
  • San Diego (246)
  • Rocky Mountain (166)
  • Philadelphia (140)
  • Omaha (137)
  • Louisville (81)
  • Caribbean (79)
  • Caribbean (1)
  • Atlanta (777)
  • Headquarters (414)
Clear All Results
1186 Results - Showing 741 to 750
PRESS RELEASE

Acting Manhattan U.S. Attorney And DEA Announce Provisional Arrest In London Of Pakistani National For Drug-trafficking On A Massive Scale

MANHATTAN, N.Y. - Joon H. Kim, the Acting United States Attorney for the Southern District of New York, and Raymond Donovan, the Special Agent-in-Charge of the Special Operations Division of the U.S. Drug Enforcement Administration today announced that Muhammad Asif Hafeez, aka “Sultan,” was provisionally arrested in London pursuant to...
PRESS RELEASE

DEA Investigations Lead To Largest Treasury Kingpin Designation Against Mexican Cartel

WASHINGTON, D.C. - As a result of several long-term DEA investigations, the U.S. Department of the Treasury’s Office of Foreign Assets (OFAC) today identified Mexican national Raul Flores Hernandez and the Flores Drug Trafficking (Flores DTO) as Significant Foreign Narcotics Traffickers pursuant to the Foreign Narcotics Kingpin Designation (Kingpin Act)...
PRESS RELEASE

DEA Proposes Reduction To Amount Of Controlled Substances To Be Manufactured In 2018

WASHINGTON, D.C. - The U.S. Drug Enforcement Administration is proposing a reduction for controlled substances that may be manufactured in the U.S. next year by 20 percent as compared to 2017, per the proposed notice being published in the Federal Register on August 7, 2017 and available for public inspection...
PRESS RELEASE

AlphaBay, The Largest Online ‘dark Market,’ Shut Down

WASHINGTON, D.C. - The Justice Department today announced the seizure of the largest criminal marketplace on the Internet, AlphaBay, which operated for over two years on the dark web and was used to sell deadly illegal drugs, stolen and fraudulent identification documents and access devices, counterfeit goods, malware and other...
PRESS RELEASE

Roswell Woman Indicted On Federal Charges For Counterfeit Oxycodone Pills Containing Fentanyl & Synthetic Opioids

ATLANTA, Ga. - Cathine Lavina Sellers of Roswell, Georgia, has been arraigned on federal charges of possession with the intent to distribute fentanyl, and two synthetic opioids, furanyl-fentanyl and U-47700. A search warrant affidavit in the case alleges that Sellers was selling counterfeit 30mg (oxycodone) pills out of her residence...
PRESS RELEASE

National Health Care Fraud Takedown: Charges Against Over 412 Individuals Responsible For $1.3 Billion In Fraud

WASHINGTON, D.C. - Attorney General Jeff Sessions and Department of Health and Human (HHS) Secretary Tom Price, M.D., announced today the largest ever health care fraud enforcement action by the Medicare Fraud Strike Force, involving 412 charged defendants across 41 federal districts, including 115 doctors, nurses and other licensed medical...
PRESS RELEASE

DEA Launches CampusDrugPrevention.gov: Targets College Drug Use

WASHINGTON, D.C. - The U.S. Drug Enforcement Administration today launched CampusDrugPrevention.gov, a new website focused on preventing and addressing college drug use. “We must talk to folks about the dangers and consequences of drug abuse, and base those conversations on facts and science,” said DEA Acting Administrator Chuck Rosenberg. “With...
PRESS RELEASE

Mallinckrodt Agrees To Pay $35 Million Settlement

WASHINGTON, D.C. - Mallinckrodt LLC, a pharmaceutical manufacturer and one of the largest manufacturers of generic oxycodone, agreed to pay $35 million to settle allegations that it violated certain provisions of the Controlled Substances (CSA) that are subject to civil penalties, Attorney General Jeff Sessions of the Justice Department and...
PRESS RELEASE

Chattanooga Drug Dealer Whose Heroin Led To Death Pleads Guilty

CHATTANOOGA, Tenn. - On June 28, 2017, Darius Jermaine Blakemore, a.k.a. Tank, 28, of Chattanooga, Tennessee pled guilty to conspiracy to distribute heroin resulting in death, distribution of heroin resulting in death, possession with intent to distribute cocaine, possession with intent to distribute crack, and possession with intent to distribute...
PRESS RELEASE

Law Enforcement Officer Arraigned For Compromising Drug Investigation

ROME, Ga. - Bryson-Taylor Wayne Banks, 31, of Cartersville, Georgia, has been arraigned on multiple federal charges, including unlawfully accessing a law enforcement database and disclosure of confidential information. Banks was a Cartersville Police Officer who was assigned to a DEA task force and allegedly used his access to law...

Pagination

  • First page «
  • Previous
  • Page 71
  • Page 72
  • Page 73
  • Page 74
  • Current page 75
  • Page 76
  • Page 77
  • Page 78
  • Page 79
  • Next
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster